Spirometry evaluation to assess performance of a claims-based predictive model identifying patients with undiagnosed COPD

A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of the aforementioned model using prospectively collected spirometry data. A study population aged 40-89 years enrolled in a Medicare Advantage pl...

Full description

Saved in:
Bibliographic Details
Published in:International journal of chronic obstructive pulmonary disease 2019-01, Vol.14, p.439-446
Main Authors: Moretz, Chad, Annavarapu, Srinivas, Luthra, Rakesh, Goldfarb, Seth, Renda, Andrew, Shaikh, Asif, Kaila, Shuchita
Format: Article
Language:English
Subjects:
Administrative Claims, Healthcare
Adrenergic beta-Agonists - therapeutic use
Adult
Aged
Aged, 80 and over
Body mass index
Bronchodilator Agents - therapeutic use
Cholinergic Antagonists - therapeutic use
Chronic obstructive pulmonary disease
clinical validation
COPD
Data collection
Data Mining - methods
Databases, Factual
Drugs
Enrollments
exacerbation
Female
Forced Expiratory Volume
Health maintenance organizations
Humans
Identification
Lung - drug effects
Lung - physiopathology
Male
Medical research
Medicare
Medicare Part C
Medicine, Experimental
Middle Aged
Original Research
Patients
Population
predictive model
Predictive Value of Tests
Prescribing
prevention
Prospective Studies
Pulmonary Disease, Chronic Obstructive - diagnosis
Pulmonary Disease, Chronic Obstructive - drug therapy
Pulmonary Disease, Chronic Obstructive - physiopathology
Reproducibility of Results
Retrospective Studies
Smoking
Smoking Cessation - methods
Smoking Cessation Agents - therapeutic use
Spirometry
Tuberculosis
United States
Vital Capacity
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:A claims-based model to predict patients likely to have undiagnosed COPD was developed by Moretz et al in 2015. This study aims to assess the performance of the aforementioned model using prospectively collected spirometry data. A study population aged 40-89 years enrolled in a Medicare Advantage plan with prescription drug coverage or commercial health plan and without a claim for COPD diagnosis was identified from April 1, 2012 to March 31, 2016 in the Humana claims database. This population was stratified into subjects likely or unlikely to have undiagnosed COPD using the claims-based predictive model. Subjects were randomly selected for spirometry evaluation of FEV and FVC. The predictive model was validated using airflow limitation ratio (FEV /FVC
ISSN:1178-2005
1176-9106
1178-2005
DOI:10.2147/COPD.S187947